194 related articles for article (PubMed ID: 38334171)
21. miR-142-3p improves paclitaxel sensitivity in resistant breast cancer by inhibiting autophagy through the GNB2-AKT-mTOR Pathway.
Shi Y; Wang J; Tao S; Zhang S; Mao L; Shi X; Wang W; Cheng C; Shi Y; Yang Q
Cell Signal; 2023 Mar; 103():110566. PubMed ID: 36539001
[TBL] [Abstract][Full Text] [Related]
22. Radix Tetrastigma Extracts Enhance the Chemosensitivity in Triple-Negative Breast Cancer Via Inhibiting PI3K/Akt/mTOR-Mediated Autophagy.
Zhang S; Cui T; Duan Y; Zhang H; Wang B; Chen H; Ni J; Shen Y; Xiao-Ai Lv
Clin Breast Cancer; 2022 Feb; 22(2):89-97. PubMed ID: 34535390
[TBL] [Abstract][Full Text] [Related]
23. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].
Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH
Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477
[TBL] [Abstract][Full Text] [Related]
24. Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway.
Guo M; Liu M; Li W; Wang C; Zhang L; Zhang H
J Cancer Res Clin Oncol; 2024 Mar; 150(3):155. PubMed ID: 38526702
[TBL] [Abstract][Full Text] [Related]
25. Near-infrared photothermal therapy using EGFR-targeted gold nanoparticles increases autophagic cell death in breast cancer.
Zhang M; Kim HS; Jin T; Moon WK
J Photochem Photobiol B; 2017 May; 170():58-64. PubMed ID: 28390259
[TBL] [Abstract][Full Text] [Related]
26. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
Chang CH; Bijian K; Wernic D; Su J; da Silva SD; Yu H; Qiu D; Asslan M; Alaoui-Jamali MA
Autophagy; 2019 Aug; 15(8):1376-1390. PubMed ID: 30773992
[TBL] [Abstract][Full Text] [Related]
27. Combination therapy with BYL719 and LEE011 is synergistic and causes a greater suppression of p-S6 in triple negative breast cancer.
Yuan Y; Wen W; Yost SE; Xing Q; Yan J; Han ES; Mortimer J; Yim JH
Sci Rep; 2019 May; 9(1):7509. PubMed ID: 31101835
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of FOXO1‑mediated autophagy promotes paclitaxel‑induced apoptosis of MDA‑MB‑231 cells.
Xu K; Zhu W; Xu A; Xiong Z; Zou D; Zhao H; Jiao D; Qing Y; Jamal MA; Wei HJ; Zhao HY
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 35014689
[TBL] [Abstract][Full Text] [Related]
29. MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway.
Wei S; Zhang Y; Ma X; Yao Y; Zhou Q; Zhang W; Zhou C; Zhuang J
Sci Rep; 2023 Jul; 13(1):12351. PubMed ID: 37524857
[TBL] [Abstract][Full Text] [Related]
30. Metadherin inhibits chemosensitivity of triple-negative breast cancer to paclitaxel via activation of AKT/GSK-3β signaling pathway.
Chang Y; Jia HQ; Xu B; Yang L; Xu YT; Zhang JY; Wang MQ; Yang LX; Song ZC
Chem Biol Drug Des; 2024 Jan; 103(1):e14416. PubMed ID: 38093418
[TBL] [Abstract][Full Text] [Related]
31. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
32. SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.
Zhang M; Liu S; Chua MS; Li H; Luo D; Wang S; Zhang S; Han B; Sun C
Cell Death Dis; 2019 Aug; 10(8):612. PubMed ID: 31406106
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Akt/mTOR pathway overcomes intrinsic resistance to dasatinib in triple-negative breast cancer.
Haga Y; Higashisaka K; Yang L; Sekine N; Lin Y; Tsujino H; Nagano K; Tsutsumi Y
Biochem Biophys Res Commun; 2020 Dec; 533(4):672-678. PubMed ID: 33036754
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38.
Gohr K; Hamacher A; Engelke LH; Kassack MU
BMC Cancer; 2017 Nov; 17(1):711. PubMed ID: 29100507
[TBL] [Abstract][Full Text] [Related]
35. Sericin inhibits MDA‑MB‑468 cell proliferation via the PI3K/Akt pathway in triple‑negative breast cancer.
Niu L; Yang S; Zhao X; Liu X; Si L; Wei M; Liu L; Cheng L; Qiao Y; Chen Z
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313947
[TBL] [Abstract][Full Text] [Related]
36. Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway.
Yu XS; Du J; Fan YJ; Liu FJ; Cao LL; Liang N; Xu DG; Zhang JD
Oncotarget; 2016 Nov; 7(47):76827-76839. PubMed ID: 27765907
[TBL] [Abstract][Full Text] [Related]
37. Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway.
Massihnia D; Galvano A; Fanale D; Perez A; Castiglia M; Incorvaia L; Listì A; Rizzo S; Cicero G; Bazan V; Castorina S; Russo A
Oncotarget; 2016 Sep; 7(37):60712-60722. PubMed ID: 27474173
[TBL] [Abstract][Full Text] [Related]
38. MAPK4 promotes triple negative breast cancer growth and reduces tumor sensitivity to PI3K blockade.
Wang W; Han D; Cai Q; Shen T; Dong B; Lewis MT; Wang R; Meng Y; Zhou W; Yi P; Creighton CJ; Moore DD; Yang F
Nat Commun; 2022 Jan; 13(1):245. PubMed ID: 35017531
[TBL] [Abstract][Full Text] [Related]
39. Ginkgolic acid induces apoptosis and autophagy of endometrial carcinoma cells via inhibiting PI3K/Akt/mTOR pathway in vivo and in vitro.
Zhou L; Li S; Sun J
Hum Exp Toxicol; 2021 Dec; 40(12):2156-2164. PubMed ID: 34132136
[TBL] [Abstract][Full Text] [Related]
40. CCL26 is upregulated by nab-paclitaxel in pancreatic cancer-associated fibroblasts and promotes PDAC invasiveness through activation of the PI3K/AKT/mTOR pathway.
Chen X; An Y; Zhang Y; Xu D; Chen T; Yang Y; Chen W; Wu D; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):612-619. PubMed ID: 33764366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]